Literature DB >> 16128714

Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98.

Keith Humphreys1, Kenneth R Weingardt, Doyanne Horst, Asha A Joshi, John W Finney.   

Abstract

AIMS: To describe the eligibility criteria (i.e. study participant inclusion and exclusion rules) employed in alcohol treatment outcome research and to identify predictors of their use.
DESIGN: The eligibility criteria of 683 alcohol treatment outcome studies conducted between 1970 and 1998 were coded reliably into 14 general categories. Predictors of the use of eligibility criteria were then examined.
FINDINGS: Patients were most often ruled ineligible for research studies because of their level of alcohol problems (39.1% of studies), comorbid psychiatric problems (37.8%), past or concurrent utilization of alcohol treatment (31.8%), co-occurring medical conditions (31.6%), and because they were deemed non-compliant and unmotivated (31.5%). The number of eligibility criteria employed in studies increased from the 1970s through the 1990s, and was positively associated with funding from the US National Institute of Alcohol Abuse and Alcoholism (NIAAA) and from the private sector, lack of an inpatient/residential treatment condition, presence of a pharmacotherapy, and use of a randomized, multiple-condition design. Principal investigators with doctoral degrees used more eligibility criteria than those with lower degrees.
CONCLUSION: Participant eligibility criteria are extensively employed in alcohol treatment outcome research, and vary significantly across historical periods, funders and research designs. Researchers should report the details of subject eligibility criteria and excluded patients more fully, and, evaluate how eligibility criteria affect the cost, feasibility, and generalizability of treatment outcome research.

Entities:  

Mesh:

Year:  2005        PMID: 16128714     DOI: 10.1111/j.1360-0443.2005.01175.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  17 in total

1.  Generalizability of clinical trials for cannabis dependence to community samples.

Authors:  Mayumi Okuda; Deborah S Hasin; Mark Olfson; Sharaf S Khan; Edward V Nunes; Ivan Montoya; Shang-Min Liu; Bridget F Grant; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  What have we learned about trial design from NIMH-funded pragmatic trials?

Authors:  John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

3.  Community program therapist adherence and competence in motivational enhancement therapy.

Authors:  Steve Martino; Samuel A Ball; Charla Nich; Tami L Frankforter; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2008-03-06       Impact factor: 4.492

4.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

5.  Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.

Authors:  Ryoko Susukida; Rosa M Crum; Cyrus Ebnesajjad; Elizabeth A Stuart; Ramin Mojtabai
Journal:  Addiction       Date:  2017-03-16       Impact factor: 6.526

6.  Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research.

Authors:  Keith Humphreys; Alex H S Harris; Kenneth R Weingardt
Journal:  J Stud Alcohol Drugs       Date:  2008-09       Impact factor: 2.582

Review 7.  Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials.

Authors:  Donna M Zulman; Jeremy B Sussman; Xisui Chen; Christine T Cigolle; Caroline S Blaum; Rodney A Hayward
Journal:  J Gen Intern Med       Date:  2011-02-01       Impact factor: 5.128

8.  Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community samples.

Authors:  Nicolas Hoertel; Saioa López; Shuai Wang; Ana González-Pinto; Frédéric Limosin; Carlos Blanco
Journal:  Personal Disord       Date:  2015-01

Review 9.  Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders.

Authors:  Katie Witkiewitz; John W Finney; Alex H S Harris; Daniel R Kivlahan; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2015-08-11       Impact factor: 3.455

10.  Recruitment for a guided self-help binge eating trial: potential lessons for implementing programs in everyday practice settings.

Authors:  Lynn L DeBar; Bobbi Jo Yarborough; Ruth H Striegel-Moore; Francine Rosselli; Nancy Perrin; G Terence Wilson; Helena C Kraemer; Rory Green; Frances Lynch
Journal:  Contemp Clin Trials       Date:  2009-03-09       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.